Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade

@article{Youn1999VentricularRA,
  title={Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade},
  author={Tae-Jin Youn and H.-S. Kim and Byung Hee Oh},
  journal={Basic Research in Cardiology},
  year={1999},
  volume={94},
  pages={246-253}
}
  • T. YounH. KimB. Oh
  • Published 1 August 1999
  • Biology, Medicine
  • Basic Research in Cardiology
Abstract With the application of early reperfusion therapy after acute MI, the incidence and importance of nontransmural infarction is increasing. In a rat model with nontransmural infarction, we evaluated 1) the changes of LV dimension, LV interstitial fibrosis and transforming growth factor-β1 (TGF-β1) mRNA expression and 2) the effects of angiotensin converting enzyme (ACE) inhibitor and angiotensin II type 1 (AT1) receptor antagonist treatment. Female Sprague-Dawley rats were subjected to… 

Connective Tissue Growth Factor and Cardiac Fibrosis after Myocardial Infarction

  • R. DeanL. Balding L. Burrell
  • Biology, Medicine
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
  • 2005
There were temporal and regional differences in the expression of TGF-β1, CTGF, and collagen after MI, and the antifibrotic benefits of captopril are not mediated through a reduction in CTGF.

Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHR.

  • T. ZdrojewskiP. Gaudron G. Ertl
  • Biology, Medicine
    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
  • 2002

Inhibition of nitric oxide synthesis increases apoptotic cardiomyocyte death and myocardial angiotensin-converting enzyme gene expression in ischemia/reperfusion-injured myocardium of rats

The inhibition of NO synthesis increased apoptotic cardiomyocyte death and local ACE mRNA expression in the I/R-injured myocardium, and observations indicate that NO, ACE, and apoptoticCardiomyocytes death are related to each other during I-R injury.

Cardiac Fibrogenesis Following Infarction in Mice With Deletion of Inducible Nitric Oxide Synthase

The current study suggests that iNOS-induced nitric oxide production may not mediate cardiac fibrosis after MI, and other mechanisms are involved in nitrosative stress-induced cardiac dysfunction after MI.

Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP–1) and its inhibitor (TIMP–1) in DCM patients

The overexpression of MMP–1, which is associated with an increased ratio of M MP–1/TIMP–1 in DCM, indicates an activated collagenolytic system while replacement fibrosis is accumulating.

A PATHOLOGIC ROLE FOR ANGIOTENSIN II AND ENDOTHELIN-1 IN CARDIAC REMODELLING AND ISCHAEMIA AND REPERFUSION INJURY IN A RAT MODEL OF THE METABOLIC SYNDROME.

Develop and characterize a rodent model of dietinduced obesity and the MS, investigate the susceptibility of hearts from these animals to ischaemia/reperfusion induced injury and determine whether angiotensin II (Ang II) and endothelin-1 (ET-1) plays a role in cardiac remodelling and/or the severity of ischaemic and reperfusion injury in this model.

Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin–angiotensin system

Since blockade of RAS partially improves cardiac function, it is suggested that a combination therapy involving RAS blockers and agents that affect other neurohumoral systems may prove useful for improved treatment of CHF.

The Possible Beneficial Effect of Angiotensin II Receptor Antagonist (Losartan) in Experimental- Hepatic Fibrosis in Albino Rats. Histological, Immunohistochemical and Biochemical Study

It is found that losartan has a benifical effect in liver fibrosis induced by BDL, however, further study for its usefulness in human hepatic fibrosis is recommended.

A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury

Current data suggest that angiotensin II may contribute to obesity induced cardiac remodelling and ischaemic/reperfusion injury, and blood pressure, and heart weight to body weight ratios.

References

SHOWING 1-10 OF 34 REFERENCES

Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

It is demonstrated that inhibition of generation of angiotensin II and AT1 receptor blockade are equally effective in preventing important features of ventricular remodeling after myocardial infarction and failure and restores minimal coronary vascular resistance in postinfarction reactive hypertrophy.

Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.

Kinins inhibit the interstitial accumulation of collagen but do not modulate cardiomyocyte hypertrophy after MI, which is related to a reduced generation/receptor blockade of angiotensin II.

Transforming growth factor beta-1 in acute myocardial infarction in rats.

A significant role for TGF-beta in the response of the heart to injury is indicated, as shown by the results of immunohistochemical staining and Northern blot analysis of mRNA.

Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats

The results show that hypertension causes not only left ventricular hypertrophy but also molecular transition of myocardium to a foetal phenotype and interstitial fibrosis‐related molecular changes.

Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes.

The view that TGF-beta 1, released by myocytes and acting in an autocrine and/or paracrine manner, is involved in myocardial remodeling by hypertrophic stimuli is supported.

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

Results indicate that Ang II induces mesangial cell synthesis of matrix proteins and show that these effects are mediated by Ang II induction of TGF-beta expression, which may well contribute to glomerulosclerosis in vivo.

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

The phenotypic changes of cardiac cells in response to Ang II in vitro closely mimic those of growth factor response in vitro and of load-induced hypertrophy in vivo, and all biological effects of Ang II examined here are mediated primarily by the AT1 receptors.

Altered Left Ventricular Remodeling With βd‐Adrenergic Blockade and Exercise After Coronary Reperfusion in Rats

Evidence is provided for altered LV remodeling, including LV cavity dilation and reduced wall thickness, after 3 weeks of propranolol treatment in sedentary rats after coronary artery occlusion and reperfusion to produce nontransmural infarction.

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis.

The protective effect of inhibition of the renin-angiotensin system in experimental and human kidney diseases correlates closely with the suppression of transforming growth factor-beta production, suggesting that transforming growthfactor-beta, in addition to blood pressure, should be a therapeutic target.

Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta.

Results suggest a potential mechanism whereby Ang II might regulate smooth muscle cell mitogenesis after vascular injury and implicates other autocrine factors in mediation of Ang II effects.